EPTIFIBATIDE MEDICIANZ (Medsurge Pharma Pty Ltd)
Product name
EPTIFIBATIDE MEDICIANZ
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
126 (255 working days)
Active ingredients
eptifibatide
Registration type
New generic medicine
Indication
TRADE NAME is indicated for patients undergoing nonurgent percutaneous coronary intervention with intracoronary stenting (see Section 5.1 Pharmacodynamic Properties, Clinical trials).
TRADE NAME is indicated for the treatment of patients with unstable angina or non-Q-wave myocardial infarction (see Section 5.1 Pharmacodynamic Properties, Clinical trials).